PubMed

Dendritic cell-based vaccines for pancreatic cancer and melanoma.

Mulé JJ.

Ann N Y Acad Sci. 2009 Sep;1174:33-40.PMID: 19769734 [PubMed - indexed for MEDLINE]Related articles

Ectopic lymph nodes within human solid tumors.

Coppola D, Mulé JJ.

J Clin Oncol. 2008 Sep 20;26(27):4369-70. No abstract available. PMID: 18802146 [PubMed - indexed for MEDLINE]Related articles

Phase Ib trial assessing autologous, tumor-pulsed dendritic cells as a vaccine administered with or without IL-2 in patients with metastatic melanoma.

Redman BG, Chang AE, Whitfield J, Esper P, Jiang G, Braun T, Roessler B, Mulé JJ.

J Immunother. 2008 Jul-Aug;31(6):591-8.PMID: 18528294 [PubMed - indexed for MEDLINE]Related articlesFree article

Nonmyeloablative chemotherapy followed by T-cell adoptive transfer and dendritic cell-based vaccination results in rejection of established melanoma.

Koike N, Pilon-Thomas S, Mulé JJ.

J Immunother. 2008 May;31(4):402-12.PMID: 18391755 [PubMed - indexed for MEDLINE]Related articles

Bif-1 interacts with Beclin 1 through UVRAG and regulates autophagy and tumorigenesis.

Takahashi Y, Coppola D, Matsushita N, Cualing HD, Sun M, Sato Y, Liang C, Jung JU, Cheng JQ, Mulé JJ, Pledger WJ, Wang HG.

Nat Cell Biol. 2007 Oct;9(10):1142-51. Epub 2007 Sep 23.PMID: 17891140 [PubMed - indexed for MEDLINE]Related articlesFree article

To ablate or not to ablate? HSCs in the T cell driver's seat.

Anasetti C, Mulé JJ.

J Clin Invest. 2007 Feb;117(2):306-10.PMID: 17273553 [PubMed - indexed for MEDLINE]Related articlesFree article

Early vaccination with tumor-lysate-pulsed dendritic cells after allogeneic bone marrow transplantation has antitumor effects.

Moyer JS, Maine G, Mulé JJ.

Biol Blood Marrow Transplant. 2006 Oct;12(10):1010-9.PMID: 17084367 [PubMed - indexed for MEDLINE]Related articles

Immunostimulatory effects of CpG-ODN upon dendritic cell-based immunotherapy in a murine melanoma model.

Pilon-Thomas S, Li W, Briggs JJ, Djeu J, Mulé JJ, Riker AI.

J Immunother. 2006 Jul-Aug;29(4):381-7.PMID: 16799333 [PubMed - indexed for MEDLINE]Related articles

Allogeneic and autologous melanoma vaccines: where have we been and where are we going?

Sondak VK, Sabel MS, Mulé JJ.

Clin Cancer Res. 2006 Apr 1;12(7 Pt 2):2337s-2341s. Review.PMID: 16609055 [PubMed - indexed for MEDLINE]Related articlesFree article

Induction of anti-tumor immunity by vaccination with dendritic cells pulsed with anti-CD44 IgG opsonized tumor cells.

Pilon-Thomas S, Verhaegen M, Kuhn L, Riker A, Mulé JJ.

Cancer Immunol Immunother. 2006 Oct;55(10):1238-46. Epub 2005 Nov 29.PMID: 16315029 [PubMed - indexed for MEDLINE]Related articles

Dendritic cell-based vaccines for cancer therapy.

Grolleau A, Sloan A, Mulé JJ.

Cancer Treat Res. 2005;123:181-205. Review. No abstract available. PMID: 16211871 [PubMed - indexed for MEDLINE]Related articles

Dendritic cell-based therapeutics for breast cancer.

Pilon-Thomas SA, Verhaegen ME, Mulé JJ.

Breast Dis. 2004;20:65-71. Review.PMID: 15687708 [PubMed - indexed for MEDLINE]Related articles

Translation of cancer immunotherapies.

Mulé JJ, Weber JS.

Nat Med. 2004 Nov;10(11):1153; author reply 1153-4. No abstract available. PMID: 15516900 [PubMed - indexed for MEDLINE]Related articles

Augmentation of antitumor immune responses after adoptive transfer of bone marrow derived from donors immunized with tumor lysate-pulsed dendritic cells.

Asavaroengchai W, Kotera Y, Koike N, Pilon-Thomas S, Mulé JJ.

Biol Blood Marrow Transplant. 2004 Aug;10(8):524-33.PMID: 15282530 [PubMed - indexed for MEDLINE]Related articles

Current developments of immunotherapy in the clinic.

Antonia S, Mulé JJ, Weber JS.

Curr Opin Immunol. 2004 Apr;16(2):130-6. Review.PMID: 15023403 [PubMed - indexed for MEDLINE]Related articles

Chemokine gene modification of human dendritic cell-based tumor vaccines using a recombinant adenoviral vector.

Terando A, Roessler B, Mulé JJ.

Cancer Gene Ther. 2004 Mar;11(3):165-73.PMID: 14726959 [PubMed - indexed for MEDLINE]Related articles

Inducible expression of macrophage receptor Marco by dendritic cells following phagocytic uptake of dead cells uncovered by oligonucleotide arrays.

Grolleau A, Misek DE, Kuick R, Hanash S, Mulé JJ.

J Immunol. 2003 Sep 15;171(6):2879-88.PMID: 12960310 [PubMed - indexed for MEDLINE]Related articlesFree article

On combining antineoplastic drugs with tumor vaccines.

Terando A, Mulé JJ.

Cancer Immunol Immunother. 2003 Nov;52(11):680-5. Epub 2003 Aug 29. Review. No abstract available. PMID: 12955481 [PubMed - indexed for MEDLINE]Related articles

Enhancing dendritic cell-based vaccines by gene modification.

Terando A, Mulé JJ.

Blood Cells Mol Dis. 2003 Jul-Aug;31(1):80-3. Review. No abstract available. PMID: 12850489 [PubMed - indexed for MEDLINE]Related articles

Making room for T cells.

Maine GN, Mulé JJ.

J Clin Invest. 2002 Jul;110(2):157-9. Review. No abstract available. PMID: 12122106 [PubMed - indexed for MEDLINE]Related articlesFree article

A phase I trial of tumor lysate-pulsed dendritic cells in the treatment of advanced cancer.

Chang AE, Redman BG, Whitfield JR, Nickoloff BJ, Braun TM, Lee PP, Geiger JD, Mulé JJ.

Clin Cancer Res. 2002 Apr;8(4):1021-32.PMID: 11948109 [PubMed - indexed for MEDLINE]Related articlesFree article

Tumor lysate-pulsed dendritic cells can elicit an effective antitumor immune response during early lymphoid recovery.

Asavaroengchai W, Kotera Y, Mulé JJ.

Proc Natl Acad Sci U S A. 2002 Jan 22;99(2):931-6. Epub 2002 Jan 15.PMID: 11792864 [PubMed - indexed for MEDLINE]Related articlesFree article

The dynamics of the T-cell antitumor response: chemokine-secreting dendritic cells can prime tumor-reactive T cells extranodally.

Kirk CJ, Hartigan-O'Connor D, Mulé JJ.

Cancer Res. 2001 Dec 15;61(24):8794-802.PMID: 11751401 [PubMed - indexed for MEDLINE]Related articlesFree article

Immune evasion by muscle-specific gene expression in dystrophic muscle.

Hartigan-O'Connor D, Kirk CJ, Crawford R, Mulé JJ, Chamberlain JS.

Mol Ther. 2001 Dec;4(6):525-33.PMID: 11735336 [PubMed - indexed for MEDLINE]Related articlesFree article

Vaccination of pediatric solid tumor patients with tumor lysate-pulsed dendritic cells can expand specific T cells and mediate tumor regression.

Geiger JD, Hutchinson RJ, Hohenkirk LF, McKenna EA, Yanik GA, Levine JE, Chang AE, Braun TM, Mulé JJ.

Cancer Res. 2001 Dec 1;61(23):8513-9.PMID: 11731436 [PubMed - indexed for MEDLINE]Related articlesFree article

Comparative analysis of necrotic and apoptotic tumor cells as a source of antigen(s) in dendritic cell-based immunization.

Kotera Y, Shimizu K, Mulé JJ.

Cancer Res. 2001 Nov 15;61(22):8105-9.PMID: 11719436 [PubMed - indexed for MEDLINE]Related articlesFree article

Dendritic cells genetically engineered to express IL-4 inhibit murine collagen-induced arthritis.

Morita Y, Yang J, Gupta R, Shimizu K, Shelden EA, Endres J, Mulé JJ, McDonagh KT, Fox DA.

J Clin Invest. 2001 May;107(10):1275-84.PMID: 11375417 [PubMed - indexed for MEDLINE]Related articlesFree article

Enhancement of tumor lysate- and peptide-pulsed dendritic cell-based vaccines by the addition of foreign helper protein.

Shimizu K, Thomas EK, Giedlin M, Mulé JJ.

Cancer Res. 2001 Mar 15;61(6):2618-24.PMID: 11289139 [PubMed - indexed for MEDLINE]Related articlesFree article

T cell-dependent antitumor immunity mediated by secondary lymphoid tissue chemokine: augmentation of dendritic cell-based immunotherapy.

Kirk CJ, Hartigan-O'Connor D, Nickoloff BJ, Chamberlain JS, Giedlin M, Aukerman L, Mule JJ.

Cancer Res. 2001 Mar 1;61(5):2062-70.PMID: 11280767 [PubMed - indexed for MEDLINE]Related articlesFree article

How much help does a vaccine-induced T-cell response need?

Weber JS, Mulé JJ.

J Clin Invest. 2001 Mar;107(5):553-4. No abstract available. PMID: 11238555 [PubMed - indexed for MEDLINE]Related articlesFree article

Local administration of dendritic cells inhibits established breast tumor growth: implications for apoptosis-inducing agents.

Candido KA, Shimizu K, McLaughlin JC, Kunkel R, Fuller JA, Redman BG, Thomas EK, Nickoloff BJ, Mulé JJ.

Cancer Res. 2001 Jan 1;61(1):228-36.PMID: 11196166 [PubMed - indexed for MEDLINE]Related articlesFree article

Tumor vaccine strategies that employ dendritic cells and tumor lysates: experimental and clinical studies.

Mulé JJ.

Immunol Invest. 2000 May;29(2):127-9. No abstract available. PMID: 10854180 [PubMed - indexed for MEDLINE]Related articles

Gene-modified dendritic cells for use in tumor vaccines.

Kirk CJ, Mulé JJ.

Hum Gene Ther. 2000 Apr 10;11(6):797-806. Review.PMID: 10779157 [PubMed - indexed for MEDLINE]Related articles

Dendritic cells: at the clinical crossroads.

Mulé JJ.

J Clin Invest. 2000 Mar;105(6):707-8. No abstract available. PMID: 10727437 [PubMed - indexed for MEDLINE]Related articlesFree article

Potentiation of immunologic responsiveness to dendritic cell-based tumor vaccines by recombinant interleukin-2.

Shimizu K, Fields RC, Redman BG, Giedlin M, Mulé JJ.

Cancer J Sci Am. 2000 Feb;6 Suppl 1:S67-75.PMID: 10685663 [PubMed - indexed for MEDLINE]Related articles

Systemic administration of interleukin 2 enhances the therapeutic efficacy of dendritic cell-based tumor vaccines.

Shimizu K, Fields RC, Giedlin M, Mulé JJ.

Proc Natl Acad Sci U S A. 1999 Mar 2;96(5):2268-73.PMID: 10051630 [PubMed - indexed for MEDLINE]Related articlesFree article

Induction of tumor antigen-specific immunity in vivo by a novel vaccinia vector encoding safety-modified simian virus 40 T antigen.

Xie YC, Hwang C, Overwijk W, Zeng Z, Eng MH, Mulé JJ, Imperiale MJ, Restifo NP, Sanda MG.

J Natl Cancer Inst. 1999 Jan 20;91(2):169-75.PMID: 9923859 [PubMed - indexed for MEDLINE]Related articlesFree article

Dendritic cell-based vaccines in the setting of peripheral blood stem cell transplantation: CD34+ cell-depleted mobilized peripheral blood can serve as a source of potent dendritic cells.

Choi D, Perrin M, Hoffmann S, Chang AE, Ratanatharathorn V, Uberti J, McDonagh KT, Mulé JJ.

Clin Cancer Res. 1998 Nov;4(11):2709-16.PMID: 9829733 [PubMed - indexed for MEDLINE]Related articlesFree article

Comparative analysis of murine dendritic cells derived from spleen and bone marrow.

Fields RC, Osterholzer JJ, Fuller JA, Thomas EK, Geraghty PJ, Mulé JJ.

J Immunother. 1998 Sep;21(5):323-39.PMID: 9789195 [PubMed - indexed for MEDLINE]Related articles

Murine dendritic cells pulsed with whole tumor lysates mediate potent antitumor immune responses in vitro and in vivo.

Fields RC, Shimizu K, Mulé JJ.

Proc Natl Acad Sci U S A. 1998 Aug 4;95(16):9482-7.PMID: 9689106 [PubMed - indexed for MEDLINE]Related articlesFree article

The role of tumor necrosis factor alpha in modulating the quantity of peripheral blood-derived, cytokine-driven human dendritic cells and its role in enhancing the quality of dendritic cell function in presenting soluble antigens to CD4+ T cells in vitro.

Chen B, Shi Y, Smith JD, Choi D, Geiger JD, Mulé JJ.

Blood. 1998 Jun 15;91(12):4652-61.PMID: 9616162 [PubMed - indexed for MEDLINE]Related articlesFree article

Identification of a T-cell receptor from a therapeutic murine T-cell clone.

Shilyansky J, Yang JC, Custer MC, Spiess P, Mixon A, Cole DJ, Mulé JJ, Rosenberg SA, Nishimura MI.

J Immunother. 1997 Jul;20(4):247-55.PMID: 9220314 [PubMed - indexed for MEDLINE]Related articles

RANTES secretion by gene-modified tumor cells results in loss of tumorigenicity in vivo: role of immune cell subpopulations.

Mulé JJ, Custer M, Averbook B, Yang JC, Weber JS, Goeddel DV, Rosenberg SA, Schall TJ.

Hum Gene Ther. 1996 Aug 20;7(13):1545-53.PMID: 8864755 [PubMed - indexed for MEDLINE]Related articles

Adoptive immunotherapy of cancer with activated lymph node cells primed in vivo with autologous tumor cells transduced with the GM-CSF gene.

Chang AE, Sondak VK, Bishop DK, Nickoloff BJ, Mulligan RC, Mulé JJ.

Hum Gene Ther. 1996 Apr 10;7(6):773-92. No abstract available. PMID: 9053030 [PubMed - indexed for MEDLINE]Related articles

Hematopoietic potential of cryopreserved and ex vivo manipulated umbilical cord blood progenitor cells evaluated in vitro and in vivo.

DiGiusto DL, Lee R, Moon J, Moss K, O'Toole T, Voytovich A, Webster D, Mule JJ.

Blood. 1996 Feb 15;87(4):1261-71.PMID: 8608214 [PubMed - indexed for MEDLINE]Related articlesFree article

A rapid and quantitative assay to estimate gene transfer into retrovirally transduced hematopoietic stem/progenitor cells using a 96-well format PCR and fluorescent detection system universal for MMLV-based proviruses.

Gerard CJ, Arboleda MJ, Solar G, Mulé JJ, Kerr WG.

Hum Gene Ther. 1996 Feb 10;7(3):343-54.PMID: 8835221 [PubMed - indexed for MEDLINE]Related articles

Genetic approaches to adoptive cellular therapy of malignancy.

Arca MJ, Mulé JJ, Chang AE.

Semin Oncol. 1996 Feb;23(1):108-17. Review.PMID: 8607021 [PubMed - indexed for MEDLINE]Related articles

Gene therapy: current status and future prospects.

Kerr WG, Mulé JJ.

J Leukoc Biol. 1994 Aug;56(2):210-4. Review.PMID: 8071597 [PubMed - indexed for MEDLINE]Related articlesFree article

Locus-specific analysis of human leukocyte antigen class I expression in melanoma cell lines.

Marincola FM, Shamamian P, Simonis TB, Abati A, Hackett J, O'Dea T, Fetsch P, Yannelli J, Restifo NP, Mulé JJ, et al.

J Immunother Emphasis Tumor Immunol. 1994 Jul;16(1):13-23.PMID: 8081556 [PubMed - indexed for MEDLINE]Related articlesFree article

Treatment of established lung metastases with tumor-infiltrating lymphocytes derived from a poorly immunogenic tumor engineered to secrete human TNF-alpha.

Marincola FM, Ettinghausen S, Cohen PA, Cheshire LB, Restifo NP, Mulé JJ, Rosenberg SA.

J Immunol. 1994 Apr 1;152(7):3500-13.PMID: 8144931 [PubMed - indexed for MEDLINE]Related articlesFree article